ATE301452T1 - Verfahren zur herstellung einer flüssigen dosierungseinheit und kit - Google Patents

Verfahren zur herstellung einer flüssigen dosierungseinheit und kit

Info

Publication number
ATE301452T1
ATE301452T1 AT01969530T AT01969530T ATE301452T1 AT E301452 T1 ATE301452 T1 AT E301452T1 AT 01969530 T AT01969530 T AT 01969530T AT 01969530 T AT01969530 T AT 01969530T AT E301452 T1 ATE301452 T1 AT E301452T1
Authority
AT
Austria
Prior art keywords
kit
producing
dosage unit
liquid dosage
liquid
Prior art date
Application number
AT01969530T
Other languages
English (en)
Inventor
David Anthony Keating
Kurt Norman
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Application granted granted Critical
Publication of ATE301452T1 publication Critical patent/ATE301452T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT01969530T 2000-07-27 2001-07-27 Verfahren zur herstellung einer flüssigen dosierungseinheit und kit ATE301452T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0018322.8A GB0018322D0 (en) 2000-07-27 2000-07-27 Pharmaceutical compositions
PCT/EP2001/008688 WO2002009666A1 (en) 2000-07-27 2001-07-27 Pharmaceutical extemporary compositions

Publications (1)

Publication Number Publication Date
ATE301452T1 true ATE301452T1 (de) 2005-08-15

Family

ID=9896370

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01969530T ATE301452T1 (de) 2000-07-27 2001-07-27 Verfahren zur herstellung einer flüssigen dosierungseinheit und kit

Country Status (7)

Country Link
EP (1) EP1303257B1 (de)
AT (1) ATE301452T1 (de)
AU (1) AU2001289762A1 (de)
DE (1) DE60112584T2 (de)
ES (1) ES2244653T3 (de)
GB (1) GB0018322D0 (de)
WO (1) WO2002009666A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080226795A1 (en) * 2007-03-14 2008-09-18 Concentrate Manufacturing Company Of Ireland Non-nutritive sweetened beverages with glycerine
GB2533669B (en) 2014-12-23 2016-12-14 Innovate Pharmaceuticals Ltd Salicylate compound composition
RS62574B1 (sr) * 2016-06-28 2021-12-31 Asamedic As Dvokomponentna kompozicija koja sadrži acetilsalicilnu kiselinu
EP3501523A1 (de) 2017-12-22 2019-06-26 Asamedic AS Zweikomponentige zusammensetzungen enthaltend acetylsalicylsäure und ein carbonatsalz
EP3501522A1 (de) 2017-12-22 2019-06-26 Asamedic AS Zusammensetzungen enthaltend acetylsalicylsäure und einem phosphatsalz
KR20230048255A (ko) * 2020-05-29 2023-04-11 베디시널스 인디아 프라이빗 리미티드 Covid-19 및 연관된 장애의 관리를 위한 조성물
US20230310276A1 (en) * 2020-09-01 2023-10-05 The Global Alliance For Tb Drug Development, Inc. Methods of preparing modified dosage forms and related components

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1204069B (it) * 1986-05-30 1989-03-01 Menarini Sas Utilizzazione della forma farmaceutica per uso orale di sali ferrosi impiegabili in terapia nelle forme di anemia da carenza di ferro
FR2686064B1 (fr) * 1992-01-15 1995-04-21 Remy Deslandes Conteneur pour la consommation d'une dose de produit liquide.
GB2272374B (en) * 1992-11-13 1996-07-03 Asta Medica Ag Stable senna extract formulations

Also Published As

Publication number Publication date
EP1303257B1 (de) 2005-08-10
WO2002009666A1 (en) 2002-02-07
GB0018322D0 (en) 2000-09-13
EP1303257A1 (de) 2003-04-23
AU2001289762A1 (en) 2002-02-13
DE60112584T2 (de) 2006-06-01
ES2244653T3 (es) 2005-12-16
DE60112584D1 (de) 2005-09-15

Similar Documents

Publication Publication Date Title
RU2002127804A (ru) Лекарственная система для лечения осложнений, связанных с диабетом, и невропатии, и их применения
BRPI0513200A (pt) uso de um anticorpo anti-igf-1r na preparação de um medicamento para tratamento combinado para malignidades não-hematológicas
ES2089027T3 (es) Forma de dosificacion transmucosica.
TW200501983A (en) Uses of anti-insulin-like growth factor I receptor antibodies
DE60115029D1 (de) Pharmazeutische zusammensetzungen enthaltend cannabidiol-derivate
ATE396967T1 (de) (5-(2-hydroxy-4-chlorbenzoyl)valeriansäure und deren salze, und zusammensetzungen zur zuführung von wirkstoffen, die diese verbindungen enthalten
ATE298324T1 (de) Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
ATE424192T1 (de) Stabile pharmazeutische zubereitungen mit 2-aza- bicyclo 3.3.0 -octan-3-carboxylsäure-derivaten
ATE301452T1 (de) Verfahren zur herstellung einer flüssigen dosierungseinheit und kit
EA200501223A1 (ru) Терапевтическая система, содержащая амоксициллин и клавулановую кислоту
ATE110269T1 (de) Ipriflavone enthaltende pharmazeutische zubereitungen, verfahren zur herstellung und therapeutische verwendung.
EA200600377A1 (ru) Новая композиция
ATE228843T1 (de) Verwendung von desoxypeganin zur behandlung von drogenabhängigkeit
KR960700701A (ko) 파라세타몰 및 l-시스테인 또는 이것의 전구물질을 함유하는 약제조성물(pharmaceutical compositions comprising paracetamol and l-cysteine or a precursor thereof)
DE50010973D1 (de) Pharmazeutische zusammensetzung, enthaltend desoxypeganin zur behandlung des alkoholismus
DE60007074D1 (de) Sulfatierte phosphatidylinositole, ihre herstellung und verwendung
ATE519492T1 (de) Intravenöse notoginseng-saponin-injektion und verfahren zur vorbereitung dieser injektion
ATE241974T1 (de) Nimelulide enthaltendes pharmazeutisches präparat zur oralen verabreichung
JPS6483024A (en) Cataplasm for cold
JPS5762221A (en) Embrocation for external use
ATE284696T1 (de) Pharmazeutische zusammensetzung enthaltend salmeterol und budesonid zur behandlung von atemkrankheiten
RU96111879A (ru) Способ приготовления гомеопатических мягких лекарственных форм
MD1780G2 (ro) Metodă de tratament al pacienţilor cu ciroze hepatice
ATE269063T1 (de) Formulierungen zur transdermalen verabreichung von fenoldopam
SE0001428D0 (sv) Treatment of hypertrophic cardiomyopathy with a substance that decreases the level of igf-i

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties